Andrew Dick is a panelist for this discussion of best practices associated with employing economists during an agency’s review of a pending merger and how the economist’s role changes if the merger is challenged. For more information, click here.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
